Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Immunic Reports IMU-838 Demonstrates Preclinical Activity Against SARS-CoV-2

americanpharmaceuticalreviewApril 24, 2020

Tag: IMU-838 , SARS-CoV-2 , Immunic

PharmaSources Customer Service